Market Cap 13.11M
Revenue (ttm) 0.00
Net Income (ttm) -11.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 233,400
Avg Vol 375,696
Day's Range N/A - N/A
Shares Out 37.77M
Stochastic %K 9%
Beta 1.60
Analysts Strong Sell
Price Target $8.30

Company Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatmen...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 799 6183
Address:
Building B, 11 HaMenofim Street, Herzliya, Israel
FreeBeerTomorrow
FreeBeerTomorrow Sep. 12 at 9:37 AM
$NRSN NeuroSense Therapeutics (NRSN) is scheduled to begin trading on a reverse-split-adjusted basis on Monday, September 14, 2026. ​Key Details: ​Ratio: 1-for-20 . The estimated post-split float is approximately 1.5 million to 1.7 million shares.
0 · Reply
et1000
et1000 Sep. 11 at 11:52 PM
Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $HUBC $NXXT $IPDN $NRSN news?
0 · Reply
TwongStocks
TwongStocks Sep. 11 at 8:07 PM
Tracking seven stocks with reverse splits on Monday - 6 on NASADQ and 1 on the NYSE American. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am Monday morning. Have to split the summary into two parts. Part 2 of 2: $NRSN 1 for 20. Will reduce outstanding shares from approx 37.94m to approx 1.90m. $NXXT 1 for 10. Will reduce outstanding shares from approx 168.4m to approx 16.84m. $OPTT 1 for 30. Will reduce outstanding shares from approx 273m to approx 9.1m.
2 · Reply
forza_juve
forza_juve Sep. 11 at 5:47 PM
$NRSN Mondays prediction. Let’s hear yours. Mine is as follows. Will begin trading around $6-6.50 Will go up and touch $8-8.50 in the first hour or so. Will get traded down and end around $5.50 Within a week you are in the $4’s Within a month you are $2.50-3.50 By Christmas (if they survive) you are looking at sub $1 and with tax loss season, it will drop further. Definitely won’t go to $18 anytime soon. My opinion obviously.
1 · Reply
lev57
lev57 Sep. 11 at 3:01 PM
$NRSN AGAIN Mr. 100. Trying to stop the increase at 0.36 towards . Again with the same method, selling and buying immediately at 0.36 . everyone together, not letting him stop the increase. Protecting our investments .
0 · Reply
lev57
lev57 Sep. 11 at 2:21 PM
$NRSN https://www.instagram.com/alonbennoon/
1 · Reply
lev57
lev57 Sep. 10 at 7:47 PM
0 · Reply
lev57
lev57 Sep. 10 at 7:42 PM
$NRSN $36 = - 10% $AGAIN Mr. 100. Trying to stop the increase at 0.36 towards . Again with the same method, selling and buying immediately at 0.36 . everyone together, not letting him stop the increase. Protecting our investments .
0 · Reply
lev57
lev57 Sep. 10 at 7:36 PM
$NRSN It doesn't make sense that a $34 deposit on a slot machine causes the exchange rate to drop by 15%. Let's unite together and protect our investment. Because of people who bet on the exchange rate to fall and are making profits on us and destroying the company and our investment that is going down the drain. Only if we unite and start buying goods will we prevent him from increasing our
0 · Reply
lev57
lev57 Sep. 10 at 7:20 PM
$NRSN For those who don't believe in the trading process and write to me that I'm talking nonsense, look at how the crash is going.
1 · Reply
Latest News on NRSN
Neurosense Therapeutics Ltd trading halted, news pending

2026-09-11T23:50:12.000Z - 1 day ago

Neurosense Therapeutics Ltd trading halted, news pending


NeuroSense initiated with a Buy at H.C. Wainwright

2026-09-03T10:05:13.000Z - 10 days ago

NeuroSense initiated with a Buy at H.C. Wainwright


NeuroSense announces redesigned development plan for PrimeC

2026-08-31T12:55:43.000Z - 13 days ago

NeuroSense announces redesigned development plan for PrimeC


NeuroSense Issues CEO Letter to Shareholders

Aug 13, 2026, 9:30 AM EDT - 4 weeks ago

NeuroSense Issues CEO Letter to Shareholders


NeuroSense Therapeutics Slides: Corporate presentation

Jul 28, 2026, 8:00 AM EDT - 6 weeks ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Therapeutics Slides: Corporate presentation

May 4, 2026, 7:00 AM EDT - 4 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Announces Pricing of Insider-Led PIPE Financing

Apr 28, 2026, 2:30 PM EDT - 4 months ago

NeuroSense Announces Pricing of Insider-Led PIPE Financing


NeuroSense announces departure of Chief Medical Officer

2026-04-26T22:31:45.000Z - 4 months ago

NeuroSense announces departure of Chief Medical Officer


NeuroSense Therapeutics Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 5 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense granted Brazilian patent covering PrimeC composition

2026-04-06T13:34:33.000Z - 5 months ago

NeuroSense granted Brazilian patent covering PrimeC composition


NeuroSense Granted Brazilian Patent Covering PrimeC Composition

Apr 6, 2026, 9:20 AM EDT - 5 months ago

NeuroSense Granted Brazilian Patent Covering PrimeC Composition


NeuroSense Therapeutics Annual report: Q4 2025

Mar 31, 2026, 9:30 AM EDT - 5 months ago

NeuroSense Therapeutics Annual report: Q4 2025


NeuroSense Therapeutics Earnings release: Q4 2025

Mar 31, 2026, 9:30 AM EDT - 5 months ago

NeuroSense Therapeutics Earnings release: Q4 2025


PrimeC New Data to Be Presented at AD/PD™ 2026 Conference

Mar 18, 2026, 8:00 AM EDT - 5 months ago

PrimeC New Data to Be Presented at AD/PD™ 2026 Conference


NeuroSense Therapeutics Slides: Corporate presentation

Mar 11, 2026, 7:00 AM EDT - 6 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense initiated with a Buy at Roth Capital

2026-03-10T08:30:39.000Z - 6 months ago

NeuroSense initiated with a Buy at Roth Capital


NeuroSense files $150M mixed securities shelf

2026-01-29T22:30:20.000Z - 7 months ago

NeuroSense files $150M mixed securities shelf


NeuroSense Therapeutics Slides: Corporate presentation

Jan 4, 2026, 7:00 AM EST - 8 months ago

NeuroSense Therapeutics Slides: Corporate presentation


NeuroSense Therapeutics Slides: Corporate Presentation

Dec 9, 2025, 7:00 AM EST - 9 months ago

NeuroSense Therapeutics Slides: Corporate Presentation


NeuroSense Therapeutics Transcript: Status Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

NeuroSense Therapeutics Transcript: Status Update


NeuroSense to Host Investor Webinar on December 8, 2025

Nov 3, 2025, 9:15 AM EST - 10 months ago

NeuroSense to Host Investor Webinar on December 8, 2025


NeuroSense files to sell 333K ordinary shares for holders

2025-10-28T20:36:43.000Z - 10 months ago

NeuroSense files to sell 333K ordinary shares for holders


NeuroSense initiated with an Outperform at Noble Capital

2025-10-14T13:35:14.000Z - 11 months ago

NeuroSense initiated with an Outperform at Noble Capital


NeuroSense Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 6:00 PM EDT - 1 year ago

NeuroSense Therapeutics Earnings release: Q2 2025


NeuroSense Therapeutics Earnings release: Q4 2024

Apr 7, 2025, 4:00 PM EDT - 1 year ago

NeuroSense Therapeutics Earnings release: Q4 2024


NeuroSense Therapeutics Annual report: Q4 2024

Apr 7, 2025, 4:00 PM EDT - 1 year ago

NeuroSense Therapeutics Annual report: Q4 2024


NeuroSense Therapeutics Earnings release: Q3 2024

Dec 18, 2024, 8:00 AM EST - 1 year ago

NeuroSense Therapeutics Earnings release: Q3 2024


FreeBeerTomorrow
FreeBeerTomorrow Sep. 12 at 9:37 AM
$NRSN NeuroSense Therapeutics (NRSN) is scheduled to begin trading on a reverse-split-adjusted basis on Monday, September 14, 2026. ​Key Details: ​Ratio: 1-for-20 . The estimated post-split float is approximately 1.5 million to 1.7 million shares.
0 · Reply
et1000
et1000 Sep. 11 at 11:52 PM
Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $HUBC $NXXT $IPDN $NRSN news?
0 · Reply
TwongStocks
TwongStocks Sep. 11 at 8:07 PM
Tracking seven stocks with reverse splits on Monday - 6 on NASADQ and 1 on the NYSE American. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am Monday morning. Have to split the summary into two parts. Part 2 of 2: $NRSN 1 for 20. Will reduce outstanding shares from approx 37.94m to approx 1.90m. $NXXT 1 for 10. Will reduce outstanding shares from approx 168.4m to approx 16.84m. $OPTT 1 for 30. Will reduce outstanding shares from approx 273m to approx 9.1m.
2 · Reply
forza_juve
forza_juve Sep. 11 at 5:47 PM
$NRSN Mondays prediction. Let’s hear yours. Mine is as follows. Will begin trading around $6-6.50 Will go up and touch $8-8.50 in the first hour or so. Will get traded down and end around $5.50 Within a week you are in the $4’s Within a month you are $2.50-3.50 By Christmas (if they survive) you are looking at sub $1 and with tax loss season, it will drop further. Definitely won’t go to $18 anytime soon. My opinion obviously.
1 · Reply
lev57
lev57 Sep. 11 at 3:01 PM
$NRSN AGAIN Mr. 100. Trying to stop the increase at 0.36 towards . Again with the same method, selling and buying immediately at 0.36 . everyone together, not letting him stop the increase. Protecting our investments .
0 · Reply
lev57
lev57 Sep. 11 at 2:21 PM
$NRSN https://www.instagram.com/alonbennoon/
1 · Reply
lev57
lev57 Sep. 10 at 7:47 PM
0 · Reply
lev57
lev57 Sep. 10 at 7:42 PM
$NRSN $36 = - 10% $AGAIN Mr. 100. Trying to stop the increase at 0.36 towards . Again with the same method, selling and buying immediately at 0.36 . everyone together, not letting him stop the increase. Protecting our investments .
0 · Reply
lev57
lev57 Sep. 10 at 7:36 PM
$NRSN It doesn't make sense that a $34 deposit on a slot machine causes the exchange rate to drop by 15%. Let's unite together and protect our investment. Because of people who bet on the exchange rate to fall and are making profits on us and destroying the company and our investment that is going down the drain. Only if we unite and start buying goods will we prevent him from increasing our
0 · Reply
lev57
lev57 Sep. 10 at 7:20 PM
$NRSN For those who don't believe in the trading process and write to me that I'm talking nonsense, look at how the crash is going.
1 · Reply
lev57
lev57 Sep. 10 at 6:26 PM
$NRSN It turns out that the cause of the decline. It is an investor or several investors together. From the site that tracks the messages. And as soon as he sees that they have caught the 100th lot. He changes the size of the lot so that they will not be able to follow him. Pay attention to the conduct of the trade.
1 · Reply
IrishSean
IrishSean Sep. 10 at 6:18 PM
$NRSN Basic situation, restated: To hit $35M MVLS with say 1.9M shares post the split, the stock needs to trade around $18-19 ie more than double the post split starting point and stay there for 10 straight trading days before Sept 29. That leaves only about two weeks to pull it off. Also as posted elsewhere : A. Sub $1M cash B. going‑concern warning C. negative equity D. no partnership E. upcoming expensive Phase 3 An inescapable conclusion is that the company is floundering. No big pharma wants to partner. No clear plan as of yet to get out of this mess or else insolvency is inevitable. Functionally insolvent now in reality. Can’t fund next phase. Need a huge catalyst. Instagram posts by the CEO is tone deaf to investors.
0 · Reply
lev57
lev57 Sep. 10 at 6:13 PM
$NRSN It doesn't make sense that a $36 deposit on a slot machine causes the exchange rate to drop by 10%. Let's unite together and protect our investment. Because of people who bet on the exchange rate to fall and are making profits on us and destroying the company and our investment that is going down the drain. Only if we unite and start buying goods will we prevent him from increasing our investment.
0 · Reply
Stekli27
Stekli27 Sep. 10 at 5:57 PM
$NRSN I think it’s fair to say that everyone at NeuroSense is pushing hard. Whatever happens from here, this doesn’t look like one of those obvious microcap scams that simply drifts toward zero while management does nothing. They are clearly trying to move the science, regulatory work and financing forward. Nobody knows whether a meaningful partnership or strategic deal will come, or whether PrimeC will eventually become another promising program that never reaches the market. But the story is not over yet. Biotech history has plenty of examples of larger pharma companies stepping in when a small, financially distressed company still owned an asset they considered valuable. I’m still heavily invested, but I’m not counting on that money. If they manage to get this over the finish line, I’ll be pleasantly surprised. If not, there are worse things that can happen 🙂
0 · Reply
lev57
lev57 Sep. 10 at 5:56 PM
$NRSN $36 = - 10% $AGAIN Mr. 100. Trying to stop the increase at 0.36 towards . Again with the same method, selling and buying immediately at 0.36 . everyone together, not letting him stop the increase. Protecting our investments .
0 · Reply
TwongStocks
TwongStocks Sep. 10 at 5:45 PM
$NRSN Equity Corporate Actions Alert #2026 - 656 Information Regarding the Reverse Stock Split and CUSIP Number Change for NeuroSense Therapeutics Ltd. (NRSN) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-656 NeuroSense Therapeutics Ltd. (NRSN) will effect a one-for-twenty (1-20) reverse split of its Ordinary Shares. The reverse stock split will become effective on Monday, September 14, 2026. In conjunction with the reverse split, the CUSIP number will change to M74240207.
0 · Reply
lev57
lev57 Sep. 10 at 2:11 PM
$NRSN Again Mr. 100. Trying to stop the increase at 0.37 0.38 towards . Again with the same method, selling and buying immediately at 0.37 0.38 . everyone together, not letting him stop the increase. Protecting our investments
0 · Reply
lev57
lev57 Sep. 10 at 1:49 PM
$NRSN https://finance.yahoo.com/healthcare/articles/neurosense-present-h-c-wainwright-130000287.html
0 · Reply
lev57
lev57 Sep. 10 at 1:27 PM
$NRSN They will try to blacken the situation for you. They will scare you. All to collect goods cheaply. The company knows where it is going. It has scientific evidence for the drug. It will comply with the laws of the SEC. And continue the experiment in a fast process. Don't be afraid and throw away goods cheaply.
0 · Reply
Stekli27
Stekli27 Sep. 10 at 11:47 AM
$NRSN The $166K cash figure is outdated. NeuroSense raised additional capital during 2026, including through its ATM and private placement, bringing pro forma cash to roughly $2.7M before subsequent burn. So the company is still under financial pressure and will likely need more funding, but saying they are basically out of cash based on $166K is misleading.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Sep. 10 at 11:16 AM
$NRSN OFF MY WATCHLIST!
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Sep. 10 at 11:09 AM
$NRSN There is a 60–75% probability of bankruptcy, liquidation, or forced asset sale within 12–18 months: 1. Core Bankruptcy Indicators (All Present): A Going‑Concern Warning (High Weight) Auditor explicitly states “substantial doubt” about continuing operations. B. Cash Near Zero (Critical) NRSN reported ~$166K cash. A Phase 3 ALS trial requires $25–40M. This is functional insolvency. C. Negative Equity Liabilities exceed assets. Companies in this condition have very high restructuring/bankruptcy rates. D. No Revenue / Single Asset Single‑asset biotechs with no revenue and no cash have among the highest bankruptcy probabilities in the market. E. Nasdaq Delisting Risk Loss of listing → loss of capital access → sharply increases bankruptcy odds. 2. Statistical Benchmarks for Similar Biotechs Clinical‑stage microcaps with: A. <$1M cash B. going‑concern warning C. negative equity D. no partnership E. upcoming expensive Phase 3 --- CoPilot
0 · Reply